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Low serum calcium is associated 
with higher long‑term mortality 
in myocardial infarction patients 
from a population‑based registry
Timo Schmitz1,2*, Christian Thilo3, Jakob Linseisen2,4, Margit Heier5,6, Annette Peters6,7, 
Bernhard Kuch8 & Christa Meisinger2,4
Calcium plays an essential role in physiology of the cardiovascular system. Aberrations from normal 
serum calcium levels are known to be associated with several cardiovascular diseases. Its possible 
role as a predictor for long‑term mortality after acute myocardial infarction (AMI) is still uncertain. 
In this study, a total of 3732 patients (aged 25–74 years) with incident AMI surviving at least 28 days 
after AMI was included. The median follow‑up time was 6.0 years. Admission total serum calcium 
levels were divided into quartiles. The Kaplan–Meier‑Curve suggested a division of the follow up 
time in two different time periods. So, Cox regression models were calculated to assess association 
between admission serum calcium levels and all‑cause long‑term mortality with two observation 
periods: 28–2500 days and > 2500 days. The final model was adjusted for various comorbidities, 
clinical characteristics, in‑hospital treatment and medication. The third quartile (normal‑high Calcium 
levels) served as the reference group. The fully adjusted Cox‑regression model shows significantly 
higher mortality risk for low serum calcium (quartile 1) within the timeframe 28–2500 days after the 
event (OR 1.53 [1.19–1.98]). The other groups did not differ significantly from each other. In the later 
observation period (from 2500 days until death or censoring) no more significant differences were 
seen between the four calcium quartiles. In summary, low serum calcium is an independent predictor 
of adverse outcome in the first 2500 days (about 7 years) after AMI. On later points in time this effect 
attenuates, so that no more significant differences can be observed.
Calcium is known to play a crucial role in pathophysiology of many  diseases1. This is particularly true for the 
cardiovascular system and its diseases. Calcium is involved in the mechanism of vasoconstriction and there-
fore influences blood pressure. Furthermore, calcium ions are an essential part of the electrical conduction in 
the  heart2. Disruptions in the calcium homeostasis can lead to serious conditions like malignant arrhythmia 
or cardiac  arrest2. Previous studies suggest, that hypocalcaemia as well as hypercalcemia might be independ-
ent risk factors for in-hospital and short-term mortality after  AMI3–5. However, only few studies examined 
associations between serum calcium levels and all-cause long-term mortality in AMI patients. Especially data 
from completely population-based registries with the possibility of multivariate adjustment for comorbidities, 
clinical characteristics and in-hospital treatment is scare. So the aim of this study was to investigate the associa-
tion between admission serum calcium levels and long-term mortality in patients with incident AMI from a 
population-based registry.
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Methods
The underlying data for this research was collected by the KORA Myocardial Infarction Registry. It was estab-
lished in 1985 as a part of the MONICA-project and since 1995 it operates within the KORA (Cooperative Health 
Research in the region of Augsburg) framework as KORA Myocardial Infarction Registry. The study area consists 
of the city of Augsburg, Germany, and the two adjacent counties of a total of approximately 650,000 inhabitants. 
All cases of fatal and non-fatal AMI are recorded, if the patients are between age 25 and 74 and have their pri-
mary residence in the study area. For this study, we considered all cases of patients, who survived the first 24 h 
after hospital admission. Trained study nurses carry out interviews using standardized questionnaire during the 
hospital stay. Further data collection is done by elaborating the patient´s medical files. In this way a large amount 
of data for each case of AMI is collected including information on sociodemographic characteristics, risk factors, 
comorbidities, diagnostics and treatment. Data on long-term survival is assessed regularly by mortality follow-
ups and information derived from the competent registration and health offices. More detailed information on 
data collection is available in previous  publications6,7.
For this study cases between January 1, 2000 and December 2008 were considered. Only patients with a first 
time myocardial infarction, who survived the first 28 days after the event, were included. Cases with missing 
information on calcium levels or missing information on relevant covariates were excluded.
Admission levels of total serum calcium were divided into quartiles: low admission calcium (0–2.18 mmol/L), 
normal-low admission calcium (2.18–2.29 mmol/L), normal-high admission calcium (2.30–2.40) and high 
admission calcium (from 2.41 mmol/). Serum levels of total calcium were measured by the laboratories of the 
participating hospital. All laboratories continuously performed internal quality control and met the official 
requirements. Maximum deviation of measured values can´t be specified due to varying measuring devices in 
different laboratories and changes over the study period of about 10 years.
Preexisting comorbidities such as diabetes, hyperlipidemia and hypertension as well as smoking status and 
typical chest pain symptoms at the event were determined during the interview and validated by chart review if 
possible. The admission ECG was evaluated by physicians. Each case was assigned to one of the following three 
groups: ST-elevation myocardial infarction (STEMI), Non-ST-evaluation myocardial infarction (NSTEMI) and 
bundle branch block.
As the kidney function has major influence on electrolyte levels, admission creatinine levels were used to 
calculate an estimated glomerular filtration rate (eGFR). Therefore, the recommended CKD-EPI-formula was 
used to calculate  eGFR8. In accordance to the WHO classification of renal function impairment four groups were 
build: normal or slightly impaired renal function with an eGFR of more than 60 mL/min/1.73 m2, mild renal 
impairment when eGFR values were between 30 and 60 mL/min/1.73 m2, severe renal impairment with eGFR 
values lower than 30 ml/min/1.73 m2 and a group of unknown renal function due to missing creatinine values.
One common variable was created for any in-hospital revascularization (yes/no). This includes percutaneous 
coronary intervention (PCI), coronary artery bypass surgery and thrombolysis therapy.
For any in-hospital complication including cardiogenic shock, left ventricular decompensation, bradycardia, 
reinfarction, ventricular tachycardia and ventricular fibrillation, one variable was generated (yes/no).
One additional variable (yes/no) was created for all four evidence-based medications at discharge (EBM): 
antiplatelet agents, beta-blockers, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin-receptor 
blockers (ARBs) and statins. All four are considered standard therapy after AMI.
Statistical analysis. Baseline characteristics and potential covariates were cross-tabulated with the four 
calcium groups. Categorical variables are presented as total number and percentages, continuous variables are 
described as median and interquartile range. To determine differences,  Chi2 test for categorical variables and 
ANOVA (analysis of variance) for continuous variable were performed. P values < 0.05 are considered statisti-
cally significant.
For long time survival, we modeled three different COX regressions. The normal-high calcium group was 
chosen to be the reference group. The first model was calculated only for admission serum calcium group. The 
second model was adjusted for sex and age. A full model then was calculated including age, sex, renal function 
(eGFR), diabetes, hypertension, smoking status, hyperlipidemia, chest pain symptoms, STEMI/NSTEMI, any 
in-hospital complication, any Intervention (PCI, Bypass, lysis therapy), diuretics before AMI, calcium channels 
blockers before AMI, diuretics at discharge calcium channels blockers at discharge, all four evidence-based 
medications (EBMs). By hand-wise selection, potential covariates were taken into the full model if they had a 
significant log rank test (P-value < 0.05) or proved to have a significant impact in a Cox-regression model together 
with admission calcium (P-value < 0.05). Peak CKMB levels did not make a significant contribution to the model 
and consequently, this variable was not included in the fully adjusted COX-regression model. Furthermore, 
C-reactive protein (CRP), which was also initially considered as a covariate, didn´t reach significance in the 
Cox-regression model and was therefore not included in the final model.
The assumption of proportional hazards was checked by plotting the Schoenefeld residuals against time and 
looking for any visible correlation. Additionally, a test was performed to check for a significant correlation of the 
Schoenfeld residuals with time and consequently a violation of the proportional hazard assumption. This was the 
case for the admission calcium group, age, smoking status, any in-hospital revascularization and any in-hospital 
complication. A non-interaction stratification was performed for smoking status, any in-hospital complication 
and any in-hospital revascularization. That means that the Cox-model was stratified for these variables, but 
only one HR was calculated from the combination of both models. Considering the Kaplan–Meier curve for 
long term survival of the four Calcium groups, it was apparent, that at about 2500 days after the event the lines 
began to violate the proportional hazards assumption. To receive valid HRs for the admission calcium groups a 
time step function was implemented including two time periods: the first 2500 days after the event and the time 
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from 2500 days until death or censoring time. The same step function was done for the age variable as well. In 
consequence, no variable showed significant correlation of the Schoenefeld residuals and time any more so that 
the proportional hazard assumption was given for every variable. Variance inflation factor (VIF) was used to 
assess multicollinearity among the independent variables.
The statistical analysis was performed by R version 3.6.1 (2019-07-05)9.
Ethics approval and consent to participate. Data collection of the MONICA/KORA MI registry has 
been approved by the ethics committee of the Bavarian Medical Association (Bayerische Landesärztekammer) 
and the study was performed in accordance with the Declaration of Helsinki. All study participants have given 
written informed consent.
Results
Between January 2000 and December 2008, a total of 6073 cases of patients with AMI, who survived the first 
24 h after hospitalization, was recorded by the registry. Of those, 424 patients died within the first 28 days after 
infarction and were excluded. Of the remaining cases, 4514 patients had a first time myocardial infarction, the 
non-incidental cases were excluded. 782 cases were excluded due to missing values on long-term survival or 
relevant covariates. In the end, 3732 cases were included into further analysis. Median age was 59.9 (SD 9.8) 
years, and 24.5% of all patients were female (n = 913). The median follow-up time was 6.0 years.
Baseline characteristics of relevant covariates are displayed in Table 1. The four serum calcium groups sig-
nificantly differed from each other in terms of age, presence of hyperlipidemia, typical chest pain symptoms, 
admission ECG, renal function (eGFR), admission troponin-I, calcium channel blockers at admission, application 
of PCI, thrombolysis, prescription of beta blockers, ACEIs/ARBs, statins, and diuretics at discharge.
Figure 1 shows the Kaplan–Meier curves for the four admission serum calcium groups. While the curves 
for normal-low group, normal-high group and high calcium group are pretty similar for the entire observation 
period, the low calcium group has a noticeably deviating graph. In the earlier stages low calcium is associated 
with higher all-cause mortality, but this trend can´t be observed for the later stages. Consequently, the follow-up 
time was divided in two time-periods, namely 28–2500 days and > 2500 days.
In the unadjusted Cox regression model low serum calcium has a significantly higher mortality from day 28 
until day 2500 (HR: 1.76). Normal-low (HR: 1.10) and high serum calcium (HR: 0.96) on the other hand do not 
vary significantly from the reference group (normal-high) in the first time period. In the second time period 
from day 2500 no calcium group differed significantly from the reference group (see Table 2).
Adjusting for sex and age did not result in a notable difference for the HR’s (see Table 2). Low serum calcium 
remains being significantly associated with higher mortality in the first time period (HR: 1.71), but not so in 
the second time period (HR: 0.70). Normal-low and high serum Calcium did not have a significantly different 
mortality risk for any of the two time periods.
The final model was further adjusted for age, sex, renal function (eGFR), diabetes, hypertension, smoking 
status, hyperlipidemia, chest pain symptoms, STEMI/NSTEMI, any in-hospital complication, any intervention 
(PCI, bypass, lysis therapy), diuretics before AMI, calcium channels blockers before AMI, diuretics at discharge, 
calcium channels blockers at discharge, all four evidence-based medications (EBMs). The result still showed a 
significant higher mortality for the low calcium group in the first time period (HR: 1.53). For the second time 
period, low serum calcium as well as normal-low and high serum calcium did not have significantly different 
mortality risks compared to the reference group (see Table 2).
Displayed in the “Supplementary material S1”, further COX-regression models were calculated. Firstly, three 
models (unadjusted, adjusted for sex and age, fully adjusted) without the distinction into the two time-periods 
were conducted. In this analysis, low serum calcium was still significantly associated with poorer long-term out-
come in the fully adjusted model resulting in a HR of 1.5 (see Supplementary Table 1). Secondly, COX-regression 
models (unadjusted, adjusted for sex and age, fully adjusted) were conducted with continuous serum total cal-
cium values. Increasing serum calcium levels were significantly inversely associated with long-term mortality 
in the first time period (HR per 1 mmol/L increase in serum calcium: 0.92; 95% CI 0.86–0.99), but not so in the 
second time period or in the total time period (see Supplementary Table 2).
Discussion
Low serum calcium is significantly associated with higher all-cause mortality in the timeframe 28–2500 days 
after AMI compared to the reference group (normal-high calcium). There is no significant difference between 
the other calcium groups in this time period. All four calcium groups did not differ from each other in the 
timeframe > 2500 days after the event. The division of the follow-up time in those two time-periods was done 
post-hoc based on Kaplan–Meier-curve and Scheonfeld analysis.
Prior studies examined in-hospital and short-term mortality for admission calcium levels after AMI. They 
found increased mortality especially for decreased admission serum  calcium3–5, but also for  hypercalcemia4. 
We excluded patients, who died within the first 28 days after the event in order to concentrate on long term 
mortality exclusively. Because our data was obtained from a multicenter survey and the admission serum cal-
cium levels were measured by different laboratories, we decided to build quartiles to categorize the cases into 
four calcium groups (low, normal-low, normal-high and high), as suggested by other studies. For the present 
study, calcium status was determined by total serum calcium measurements, a method which is widely used to 
assess calcium status of patients in daily clinical practice. About 50% of total serum calcium is present in form 
of ionized  calcium10; only ionized and free, that is not albumin-bound serum calcium is biologically  active10. 
Thus, assessment of the calcium status can also be based on the measurement of ionized calcium. Particularly 
in patients with suspected calcium disorders, calcium status estimations can differ from each other when either 
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based on total serum calcium or ionized serum  calcium11. This especially applies to certain conditions like 
hypoalbuminemia, which is why total serum calcium levels can be corrected for albumin  concentrations12. 
Nevertheless, recent studies questioned, whether albumin adjustment of total calcium does improve the estima-
tion of calcium  status13–15. Some prior studies on association of calcium levels and outcome of cardiovascular 
diseases based their analyses on ionized calcium concentrations which causes a limited comparability with this 
 study16,17. However, the majority of the previous studies also based their results on total serum calcium leading 
to a good comparability with the results of the present study.
Total serum calcium levels can be influenced by many parameters. One important factor is impaired renal 
function, which can affect serum  calcium18,19. Certain medications like diuretics and calcium channels blockers 
might influence serum calcium levels as  well20–22. Therefore, they were considered as potential covariates and 
Table 1.  Baseline characteristics of AMI patients (n = 3732) by admission total serum calcium. Categorical 
data presented as total numbers and % (proportion within each calcium group). Numeric data presented as 
median and (IQR). *Chi2 test was applied for categorical variables and ANOVA (analysis of variance) was 
applied for continuous variables. P values < 0.05 are considered statistically significant.
Low calcium Normal-low clacium Normal-high calcium High calcium p-value*
Female 214 (22.8) 236 (22.7) 267 (26.6) 196 (26) –
Age in years (mean + sd) 60.7 (9.5) 60.2 (9.9) 59.9 (9.7) 58.8 (10) 0.001
Total deaths (percentages): 
> 28–2500 days 152 (16,2%) 117 (11,3%) 106 (10,6%) 80 (10,6%) 0.00024
Total deaths (percentages): > 2500 days 8 (3.6%) 24 (6.5%) 32 (7.6%) 42 (10.8%) 0.0083
Co-morbidities and risk factors at admission
Hypertension 715 (76.3) 782 (75.2) 745 (74.4) 559 (74.2) 0.722
Diabetes mellitus 277 (29.6) 295 (28.4) 287 (28.6) 209 (27.8) 0.869
Hyperlipidemia 579 (61.8) 745 (71.6) 706 (70.5) 581 (77.2) < 0.0001
Current smoker 375 (40) 390 (37.5) 400 (39.9) 302 (40.1) 0.220
Ex-smoker 291 (31.1) 350 (33.7) 289 (28.8) 215 (28.6) –
Never-smoker 271 (28.9) 300 (28.8) 313 (31.2) 236 (31.3) –
Clinical characteristics at admission
Typical chest pain symptoms 801 (85.5) 926 (89) 895 (89.3) 643 (85.4) 0.008
STEMI 326 (34.8) 393 (37.8) 410 (40.9) 319 (42.4) 0.006
NSTEMI 546 (58.3) 598 (57.5) 546 (54.5) 401 (53.3)
Bundle branch block 65 (6.9) 49 (4.7) 46 (4.6) 33 (4.4)
Any in-hospital complication 152 (16.2) 128 (12.3) 143 (14.3) 119 (15.8) 0.062
Labaratory values at admission
eGFR < 30 mL/min/1.73 m2 31 (3.3) 7 (0.7) 12 (1.2) 9 (1.2) < 0.0001
eGFR 30–60 mL/min/1.73 m2 106 (11.3) 74 (7.1) 69 (6.9) 37 (4.9) –
eGFR   60 mL/min/1.73 m2 401 (42.8) 435 (41.8) 353 (35.2) 173 (23) –
eGFR missing value 399 (42.6) 524 (50.4) 568 (56.7) 534 (70.9) –
Admission troponin-I (ng/mL) 0.49 (0.1–2.99) 0.44 (0.1–2.88) 0.53 (0.12–3.46) 0.97 (0.16–5.785) 0.035
Peak CKMB levels 43 (14—111) 39 (15—107) 41 (15—101) 44 (17—104) 0.742
Medication at admission
Calcium channel blockers 146 (15.6) 145 (13.9) 138 (13.8) 138 (18.3) 0.034
Diuretics 184 (19.6) 179 (17.2) 190 (19) 159 (21.1) 0.206
In-hospital treatment
PCI 658 (70.2) 711 (68.4) 664 (66.3) 469 (62.3) 0.004
CABG 136 (14.5) 178 (17.1) 160 (15.9) 120 (15.9) 0.476
Thrombolysis 52 (5.5) 85 (8.2) 122 (12.1) 123 (16.3) < 0.0001
Any revascularization therapy 787 (84) 897 (86.2) 847 (84.5) 624 (82.9) 0.245
Medication at hospital discharge
All four EBMs 659 (70.3) 776 (74.6) 685 (68.4) 481 (63.9) < 0.0001
Antiplatelet agents 904 (96.5) 1002 (96.3) 970 (96.8) 724 (96.1) 0.895
Beta-blockers 898 (95.8) 1014 (97.5) 947 (94.5) 702 (93.2) 0.0001
ACEIs/ARBs 775 (82.7) 890 (85.6) 814 (81.2) 590 (78.4) 0.001
Statins 836 (89.2) 940 (90.4) 884 (88.2) 639 (84.9) 0.003
Calcium channel blockers 124 (13.2) 132 (12.7) 121 (12.1) 101 (13.4) 0.827
Diuretics 498 (53.1) 522 (50.2) 503 (50.2) 323 (42.9) 0.0003
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were kept in the model if they reached the significance criterion. Accordingly, the final model was adjusted for 
renal function and intake of diuretics and calcium channel blockers before the event.
Serum calcium is known to be a predictor of long-term mortality in different cardiovascular  diseases23,24. 
There are previous studies, which examined associations between serum calcium levels and long-term mortality 
in patients with coronary heart diseases and after  AMI25–28. Jiang et al. investigated 192 patients with ST-Elevation 
AMI and divided them into a normal calcium group and a hypocalcemia group. In a multivariate logistic regres-
sion for survival after 150 days, they found the hypocalcemia group to have significantly worse mid-term survival 
Figure 1.  Kaplan–Meier Curve: long-term survival of AMI patients after 28 days by admission serum calcium 
concentration groups, figure generated with R version 3.6.19.
Table 2.  COX-Regression models by calcium groups; an unadjusted model, a model adjusted for sex 
and age and a fully adjusted model. Two observational periods were distinguished: from 28 to 2500 days 
after incidental AMI and more than 2500 days after incidental AMI. a Adjusted for age, sex, renal function 
(eGFR), diabetes, hypertension, smoking status, hyperlipidemia, chest pain symptoms, STEMI/NSTEMI, any 
in-hospital complication, any intervention (PCI, bypass, lysis therapy), diuretics before AMI, calcium channels 
blockers before AMI, diuretics at discharge, calcium channels blockers at discharge, all four evidence-based 
medications (EBMs).
28–2500 days > 2500 days
HR (95% CI) P value HR (95% CI) P value
Unadjusted model
Calcium low 1.76 (1.37–2.25) < 0.0001 0.68 (0.31–1.48) 0.331
Calcium normal-low 1.10 (0.84–1.43) 0.487 1.05 (0.62–1.78) 0.871
Calcium normal-high 1 (Ref) – 1 (Ref) –
Calcium high 0.96 (0.72–1.29) 0.792 1.27 (0.79–2.00) 0.313
Model adjusted for sex and age
Calcium low 1.71 (1.33–2.19)  < 0.0001 0.70 (0.32–1.52) 0.363
Calcium normal-low 1.08 (0.83–1.40) 0.5778 1.02 (0.60–1.74) 0.931
Calcium normal-high 1 (Ref) – 1 (Ref) –
Calcium high 1.04 (0.77–1.38) 0.816 1.36 (0.86–2.15) 0.193
Fully adjusted modela
Calcium low 1.53 (1.19–1.98) 0.000936 0.65 (0.30–1.42) 0.284
Calcium normal-low 1.18 (0.91–1.54) 0.221 1.01 (0.59–1.72) 0.981
Calcium normal-high 1 (Ref) – 1 (Ref) –
Calcium high 0.99 (0.74–1.33) 0.954 1.32 (0.83–2.10) 0.234
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than the normal calcium  group25. A further study found similar  results26. Xingbo Gu et al. compared mid-term 
mortality of 2594 patients with acute coronary syndrome according to serum calcium. They split up the cases 
in quartiles as in the present study. Multivariate Cox-regression with a median follow-up period of 21.8 months 
showed significantly higher mortality among the lowest calcium group and no significant differences for the 
other three groups. This is very close to what we found for the first time period after the event (28–2500 days). 
In our study, this effect starts to weaken over time and no more significant differences can be found for the later 
observation time. It seems plausible, that a laboratory value has a more reliable predictive value in the nearer 
future and that its predictive value weakens as time goes on.
Researchers from a Chinese study presented similar results for patients with established coronary heart 
 diseases27. The quartile of patients with the lowest serum calcium levels had the highest risk of long-term mortal-
ity (median follow-up: 4.9 years). Higher serum calcium levels did not correlate with higher mortality.
Another study from 2012 examined associations between baseline calcium levels and risk of cardiovascular 
and all-cause mortality in a population with stable coronary heart disease. 1206 patients were followed up for 
8 years. The quartile of patients with the highest serum calcium levels had the highest risk of all-cause mortality 
compared to the other calcium  groups28. This is in a way contrary to what we found. Though, comparability is 
limited due to different time points of measurement of serum calcium levels (at time at AMI versus a stable state 
of coronary heart disease).
Nevertheless, the exact mechanisms are unclear how decreased admission calcium levels lead to a higher long-
term mortality after AMI. Blood calcium levels and intracellular calcium homoeostasis are regulated precisely and 
even small deviations can lead to organic malfunction especially in cardiac electrophysiological  processes29–31. 
Several studies found associations between decreased serum calcium levels and some cardiovascular risk factors 
such as  hypertension32,33, diabetes mellitus type  234,  smoking35 or left ventricular systolic  dysfunction36. This 
might contribute to a higher cardiovascular and all-cause mortality in the low calcium group. Nevertheless, we 
adjusted the final COX regression model for those comorbidities and low serum calcium was still a significant risk 
factor for mortality in the time between 28 and 2500 days after AMI. Nonetheless we must consider insufficient 
information on these comorbidities and therefore the possibility of residual confounding. Furthermore, we might 
not have considered all relevant confounders which can be associated with decrease serum calcium. An impor-
tant possible confounder in this regard might be the presence of a malignant disease. A study from China with 
25,000 cancer patients revealed that 26.7% of them had  hypocalcemia37. The presence of hypocalcemia was also 
associated with a higher in-hospital-mortality compared to cancer patients without any electrolyte  disorders37. 
Thongprayoon et al. examined the association of long-term mortality among hospitalized patients with various 
admission serum ionized calcium levels and found that hypocalcemia was significantly associated with higher 
long-term mortality even after multivariate  adjustment38. They suggested, that ionized serum calcium could be 
viewed as a sick index or marker of disease severity.
Furthermore, Thongprayoon et al. found that patients with low serum ionized calcium carried an increased 
risk of ventricular  arrhythmia38. It is also known, that low admission serum calcium levels are independently 
associated with an increased risk of sudden cardiac  arrest39. One decisive factor for this could be a prolonged QT 
interval, which is known to be a risk factor for sudden cardiac  death40. Some studies indeed found an associa-
tion between low serum calcium and prolonged QT interval  time41,42. Furthermore, calcium supplementation 
seems to be effective for shortening repolarization  intervals42. Nevertheless, some limitations to our study in 
this regard must be considered. Firstly, no information on patients QT interval time was available, so it is not 
possible to determine, weather low serum calcium is indeed associated with prolonged QT intervals in patients 
included in this study. Secondly, since all-cause mortality was the primary outcome of the study and no further 
information on the cause of death was available, we are no able to differentiate between mortality caused by 
sudden cardiac arrests, mortality caused by other cardiovascular diseases and non-cardiovascular mortality 
caused by other diseases.
As a consequence, we can only speculate, on whether hypocalcemic patients with AMI would benefit from 
calcium supplementation in a long term. More research is needed in this regard.
Strengths and limitations. There are several strengths of this study. First, the high number of cases from 
a population-based registry with consecutive enrollment avoids selection bias. The large amount of collected 
data on relevant covariates such as sociodemographic information, risk factors, comorbidities and information 
on in-hospital complications and treatment provides the opportunity for extensive adjustments. With a median 
follow-up time of 6.0 years the observation period after the event is quite long.
Nevertheless, the following limitations to our study must be mentioned. Since only patients up to 74 years 
were included, results cannot necessarily be applied to older patients. Moreover, the results may not be general-
ized to all ethnic groups since no information on ethnicity was available. Since this is a multicenter study, admis-
sion serum calcium levels were measured by different laboratories, which may cause some bias. Moreover, no 
information on ionized calcium concentrations and serum albumin concentrations was available. As only free 
and not albumin-bound calcium is physiologically active, this must be considered as a further limitation of this 
study. Furthermore, the outcome of the study was all-cause death and no information on the cause of death was 
available for this study. Also, no data was collected on treatment of abnormal serum calcium levels. Finally, we 
might not have considered all relevant confounders and cannot exclude possible reverse causation.
Conclusion
Low serum total calcium levels at hospital admission are independently associated with increased mortality 
after incident AMI for the time period of 28–2500 days after the event. On the time period past 2500 days, no 
more significant difference in long-term mortality is seen among the four admission serum calcium groups. It is 
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unclear though, whether patients with hypocalcemia would benefit from calcium supplementation for improved 
long-term mortality. Further studies on this subject are needed.
Data availability
The data will not be shared. Due to restrictions from Helmholtz Zentrum München, data are available upon 
request for any researcher based on a standard agreement on data provision within the KORA Research Platform.
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